Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROMIDEPSIN vs ROMOSOZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ROMIDEPSIN vs ROMOSOZUMAB: Safety Overview

Metric ROMIDEPSIN ROMOSOZUMAB
Total FAERS Reports 1,282 434
Deaths Reported 343 48
Death Rate 26.8% 11.1%
Hospitalizations 458 81
Average Patient Age 64.7 yrs 69.1 yrs
% Female Patients 46.5% 94.5%
FDA Approval Date Mar 13, 2020 N/A
Manufacturer Fresenius Kabi USA, LLC Amgen, Inc
Route N/A SUBCUTANEOUS
Marketing Status Prescription N/A